Keywords: Labs Thea, Novartis, Commercialization rights, Ophthalmic products

Labs Thea gets rights to commercialize 19 ophthalmic products from Novartis

Article | 01 April 2011

Laboratoires Thea, a France-based independent ophthalmic group, continues its expansion in ophthalmology with the announcement of the acquisition of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Laboratoires Thea

Go to company listing